4.4 Review

Costs of Invasive Meningococcal Disease: A Global Systematic Review

期刊

PHARMACOECONOMICS
卷 36, 期 10, 页码 1201-1222

出版社

ADIS INT LTD
DOI: 10.1007/s40273-018-0679-5

关键词

-

资金

  1. National Health and Medical Research Council of Australia: Career Development Fellowship [1084951]

向作者/读者索取更多资源

BackgroundInvasive meningococcal disease remains a public health concern because of its rapid onset and significant risk of death and long-term disability. New meningococcal serogroup B and combination serogroup ACWY vaccines are being considered for publicly funded immunization programs in many countries. Contemporary costing data associated with invasive meningococcal disease are required to inform cost-effectiveness analyses.ObjectiveThe objective of this study was to estimate costs and resource utilization associated with acute infection and the long-term care of invasive meningococcal disease.Data Sources and MethodsPubMed, EMBASE, The Cochrane Library, health economic databases, and electronically available conference abstracts were searched. Studies reporting any costs associated with acute infection and long-term sequelae of invasive meningococcal disease in English were included. All costs were converted into purchasing power parity-adjusted estimates [international dollars (I$)] using the Campbell and Cochrane Economics Methods Group and theEvidence for Policy and Practice Information and Coordinating Centre cost converter.ResultsFourteen studies met our eligibility criteria and were included. The mean costs of acute admission ranged from I$1629 to I$50,796, with an incremental cost of I$16,378. The mean length of hospital stay was reported to be 6-18days in multiple studies. The average costs reported for readmissions ranged from I$7905 to I$15,908. Key variables such as the presence of sequelae were associated with higher hospitalization costs and longer inpatient stay. No studies estimated directnon-healthcare costs and productivity loss. Ten studies reported only unadjusted mean values without using appropriate statistical methods for adjustment.ConclusionsInvasive meningococcal disease can result in substantial costs to healthcare systems. However, costing data on long-term follow-up and indirect costs used to populate health economic models are lacking.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据